MiLaboratories and Cellanome Enable Integrated Immune Repertoire Profiling on the R3200 Live-Cell Platform
SAN FRANCISCO and FOSTER CITY, CA – November 18, 2026

MiLaboratories, creators of the industry-standard MiXCR software for immune repertoire analysis, today announced a partnership with functional single-cell innovator Cellanome. Through this collaboration, MiXCR is natively integrated into Cellanome Cloud to power the launch of Cellanome's new 5' workflow, enabling immune repertoire analysis directly on the R3200 platform.

Cellanome’s R3200 platform links longitudinal imaging of individual cells and defined cell ensembles to single-cell transcriptomic profiles from the same cells. Its CellCage™ technology uses light to form biocompatible hydrogel enclosures around selected cells, holding them in place through culture and time-lapse imaging. At the endpoint, RNA is captured in place on the flow cell surface, so each transcript can be traced back to the addressable CellCage enclosure it came from. Recovering immune receptor sequences from this format calls for a specialized approach to analysis.

MiLaboratories developed a customized MiXCR analytical workflow that intelligently merges capture oligos in each CellCage, improving read assignment and clonotype recovery for high-fidelity immune profiling.

MiXCR has processed more than 10 million samples, has more than 2,000 citations across its papers since its first publication in Nature Methods in 2015, and is named in more than 350 US and European patents and patent applications. In Cellanome Cloud, researchers get T- and B-cell receptor analysis without setting up any computing of their own.

“The R3200 measures living cells over time and then sequences them. No other platform produces data like this.” said Stanislav Poslavsky, CEO of MiLaboratories. “We built a MiXCR workflow for this data together with Cellanome’s team. Their users now get T- and B-cell receptor analysis in the same cloud application, done with a method the field has used for more than ten years.”

By connecting T- and B-cell receptor sequences with longitudinal measurements of the same cells, the integrated workflow enables researchers to investigate immune cell identity and behavior in greater depth, opening new opportunities in immuno-oncology and cancer research.

About MiLaboratories MiLaboratories develops computational technologies for immune repertoire analysis and biologics discovery. The company is the creator of MiXCR, industry-leading software for comprehensive extraction and analysis of immune repertoires from diverse sequencing data, and Platforma, an AI-harnessed discovery decision platform that integrates complex biological data and analytical methods to support evidence-based decisions across biologics discovery programs. Trusted by leading pharmaceutical companies and academic institutions worldwide, MiLaboratories helps researchers turn complex biological data into actionable, reproducible insights.